Julien Boudreau
Overview
Explore the profile of Julien Boudreau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
2
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Correll C, Cutler A, Laliberte F, Germain G, MacKnight S, Boudreau J, et al.
Ann Gen Psychiatry
. 2025 Jan;
24(1):5.
PMID: 39871357
Background: Atypical antipsychotics are a common treatment for serious mental illness, but many are associated with adverse effects, including weight gain and cardiovascular issues, and real-world experience may differ from...
2.
Mannino D, Weng S, Germain G, Boudreau J, Tardif-Samson A, Forero-Schwanhaeuser S, et al.
Adv Ther
. 2024 Dec;
42(2):1131-1146.
PMID: 39731707
Introduction: Chronic obstructive pulmonary disease (COPD) is associated with exacerbations which can reduce quality of life and increase mortality. Single-inhaler triple therapy (SITT) is recommended for maintenance treatment of COPD...
3.
Cutler A, Laliberte F, Germain G, MacKnight S, Boudreau J, Wade S, et al.
J Med Econ
. 2024 Nov;
27(1):1472-1484.
PMID: 39531329
Aims: To evaluate the healthcare resource utilization (HRU) and costs of patients who initiated cariprazine as their first versus subsequent atypical antipsychotic (AA) following a bipolar I disorder (BP-I) diagnosis....
4.
Casale T, Corbridge T, Germain G, Laliberte F, MacKnight S, Boudreau J, et al.
Allergy Asthma Clin Immunol
. 2024 Mar;
20(1):25.
PMID: 38532489
Background: Systemic corticosteroid (SCS) use remains widespread among patients with severe asthma, despite associated complications. Objective: Evaluate the association between cumulative SCS exposure and SCS-related complications in severe asthma. Methods:...
5.
Zhdanava M, Zhao R, Manceur A, Ding Z, Boudreau J, Kachroo S, et al.
J Manag Care Spec Pharm
. 2024 Feb;
30(2):141-152.
PMID: 38308626
Background: Chronic corticosteroid use is common in ulcerative colitis (UC); however, real-world evidence of its burden to the health care system is limited. Objective: To quantify chronic corticosteroid use burden...
6.
Zhdanava M, Zhao R, Manceur A, Ding Z, Boudreau J, Kachroo S, et al.
J Am Pharm Assoc (2003)
. 2023 Nov;
64(2):386-394.e10.
PMID: 37956768
Background: Chronic corticosteroid (CS) use is associated with complications, but estimates of the economic and clinical burden in patients with Crohn's disease (CD) are lacking. Objective: To estimate the burden...
7.
Berger J, Ashton V, Laliberte F, Germain G, Bookhart B, Lejeune D, et al.
Adv Ther
. 2023 Jan;
40(3):1224-1241.
PMID: 36658454
Introduction: The healthcare resource utilization (HRU) and costs of oral anticoagulant-naïve patients with non-valvular atrial fibrillation (NVAF) and diabetes initiated on rivaroxaban or warfarin in the United States (US) has...